Status:
COMPLETED
AT GOAL: Adopting Technology for Glucose Optimization and Lifestyle in Pregnancy
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
DexCom, Inc.
Conditions:
Type2Diabetes
Pregnancy in Diabetic
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study will assess differences in patient preferences and glucose control between continuous glucose monitoring and standard glucose checks in pregnant patients with Type 2 Diabetes. 40 participan...
Detailed Description
This pilot single site randomized control trial will compare the blood glucose control and participant satisfaction scores of continuous glucose monitoring vs standard glucose checks in pregnant women...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years of age at enrollment
- Ability to consent in English
- Gestational age less than or equal to 19 weeks 6 days at enrollment
- Appropriate dating by certain LMP or ultrasound performed less than or equal to 19 weeks 6 day
- Diagnosis of Type 2 Diabetes less than or equal to 19 weeks 6 days
- Singleton gestation
Exclusion
- Age less than 18 years of age at enrollment
- Lack of appropriate dating
- Multiple gestations
- Use of concentrated insulin at enrollment (ie U500)
- Preexisting CGM in place
- Chronic use of medications known to cause hyperglycemia, such as HIV antiretrovirals and inhaled, injectable and oral corticosteroids
- Be unwilling or unable to present to Center for Perinatal Care for visits
Key Trial Info
Start Date :
August 8 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 6 2024
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05370612
Start Date
August 8 2022
End Date
October 6 2024
Last Update
January 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53715